Se hai scelto di non accettare i cookie di profilazione e tracciamento, puoi aderire all’abbonamento "Consentless" a un costo molto accessibile, oppure scegliere un altro abbonamento per accedere ad ANSA.it.
Ti invitiamo a leggere le Condizioni Generali di Servizio, la Cookie Policy e l'Informativa Privacy.
Trending
Preclinical trials of five coronavirus vaccines started in Italy on Monday.
They are all being carried out by the biotech firm Takis, results are expected by mid-May and human trials could start in the autumn, CEO Luigi Aurisicchio told ANSA.
The vaccines are based on various regions of the protein Spike, the main weapon with which the virus attacks human respiratory cells.
ALL RIGHTS RESERVED © Copyright ANSA
ANSA News Choose the information from ANSA.it
Subscribe to read all ANSA.it news without limits
Subscribe now
ANSA Corporate
If it is news,
it is an ANSA.
We have been collecting, publishing and distributing journalistic information since 1945 with offices in Italy and around the world. Learn more about our services.
Stay connected
Latest news
